August 25, 2014

Exceptional Patient Care: Highlighting MMC’s Specialties
Part 3 – MMC Pulmonology Leads Maine, Region in Diagnostics, Therapeutics, and Research
Maine Medical Center is continuously putting patients and families first by investing in our threepart mission: Caring for our
community, Educating tomorrow’s caregivers, Researching new
ways to provide care. Now we’re
taking time to highlight the hard
work of specialties which live
that mission. For eight issues of
What’s Happening, we’ll
share how each specialty is exceeding national standards of
patient care through hard work
and dedication, as recognized by
the U.S. News and World
Report’s Best Hospital
rankings.

Topping Out
The final steel beam of
Bean 2, our new surgical
unit, was lifted into place
last week — a process
called “topping out” —
completing the structural
phase of construction. The
beam was signed by hundreds of employees, many
of whom will work in the
new space.
The pine tree and flag atop
the beam is a long-held
builders’ tradition, symbolizing the successful, safe
framing of the structure and
continuing good luck.

MMC’s pulmonary program
is part of the national
ARDS (Adult Respiratory
Distress Syndrome) network for research, working
to provide the best care for
our critically ill patients.
Pulmonary works closely
with the hospital’s critical
care staff. The combined
team, the Pulmonary and
Critical Care Medicine Division, has provided education for internists looking
to become specialists for
more than 20 years. The
fellowship program is the
only one of its kind in
the state.

“Our division, collaboratively with Chest Medicine
Associates (CMA), is dedicated to quality patient care,
innovative education, and
front-line research that produces real results for our
community, region, and
nation,” says Joel Wirth,
M.D., Division Director,
Pulmonary and Critical
Care Medicine.





Advanced bronchoscopy and diagnostics
Cystic fibrosis
Pulmonary hypertension

Mayuko Fukunaga, M.D.,
leads the Advanced Bronchoscopy and Diagnostics
Program, which provides
exceptional diagnostics and
therapeutic endoscopic lung
procedures. MMC is the
In addition to achieving a
only hospital in Maine ofworking collaboration with fering Electromagnetic
critical care, MMC’s Pulmo- Navigation bronchoscopy
nary program has achieved (EMN), which can reduce
great success for our pathe need for diagnostic
tients and on a global level,
Continued on back
particularly in three areas:

Fellowship-trained in endovascular neurosurgery, Dr.
Sanborn joins the cerebrovascular/endovascular team
at MMC, specializing in the
treatment of aneurysms,
AVMs, carotid vertebral
disease, and stroke.

where he completed a pediatric urology fellowship at
Children’s Hospital of Colorado. Dr. Chalmers received his medical degree
from Wake Forest School
of Medicine in 2007 and
underwent residency at The
University of Connecticut.
The Baltimore Sun Maryland High School Runner of
David Chalmers, M.D.
the Year in 1996, and a twoDavid Chalmers, M.D.,
time Dartmouth Cross
has joined Maine Medical
Country captain, Dr.
Partners – Urology in South Chalmers is looking forward
Portland. He comes to
to exploring Maine’s many
Maine from Denver, CO
running trails.

Matthew Sanborn, M.D.
Matthew R. Sanborn,
M.D., has joined Maine
Medical Partners – Neurosurgery & Spine.

“Exceptional Patient Care” Fibrosis Foundation’s Ther- there is no cure. Together,
apeutics Development Net- MMC and CMA were one
from front
work (TDN). Through efficient study design, optimized clinical trial execution, and high-quality data,
the TDN helps speed the
delivery of new and better
therapies to people with CF.
MMC is leading the state in Dr. Zuckerman and Ted
providing comprehensive
Sears, M.D., have won comcare for adults with Cystic petitive national grants to
Fibrosis (CF) through the
support their CF research.
Adult Cystic Fibrosis Center, led by Jonathan Zucker- Pulmonary Arterial Hyperman, M.D. The MMC CF
tension (PAH) is a rare but
Center is part of the Cystic often fatal disease for which
chest surgery for certain
patients, and the program
offers the only Cardiopulmonary Exercise Testing
(CPET) in the region.

of the first programs to provide highly specialized, multi-disciplinary care for PAH
patients throughout Northern New England. The program has helped to develop
several of the new drugs
that are now available to
treat PAH, and survival for
patients with PAH has doubled in the last five years as
a result of new drugs.
“Our program has long held
a leadership role in improv-

Dr. Sanborn received his
medical degree from
Georgetown University
School of Medicine. He
completed his residency at
Hospital of the University
of Pennsylvania and his fellowship at Barrow Neurological Institute. An avid
skier and mountaineer, he is
a member of the Wilderness
Medicine Society.

ing the lives of those with
pulmonary disease,” says
Dr. Wirth. “Through participating in the development
of new drugs, our advanced
pulmonary diagnostics program, educational opportunities, and our commitment
to providing 24/7 in-house
attending-level care for critically ill patients, we are able
to enhance the lives of
some of our most critical
patients and patients across
the country.”
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